Federated Hermes Inc. reduced its position in Doximity, Inc. (NASDAQ: DOCS) by 32.5% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 186,986 shares of the co
Baird Financial Group Inc. purchased a new stake in shares of Doximity, Inc. (NASDAQ: DOCS) during the undefined quarter, according to its most recent filing with the SEC. The institutional investor p
Pre-Market Stock Futures: The futures are trading flat on Tuesday after we opened the week on the downside, with all major indices finishing the day lower. With the Federal Reserve meeting this week,
Doximity, Inc. (NASDAQ: DOCS - Get Free Report) shares reached a new 52-week low during trading on Saturday. The stock traded as low as $45.29 and last traded at $45.9260, with a volume of 6994938 sha
Doximity's Q2 results show record engagement and accelerating adoption of AI workflow tools, signaling deeper physician reliance on the platform. Revenue quality is improving as pharma clients shift f
Edgestream Partners L.P. raised its stake in Doximity, Inc. (NASDAQ: DOCS) by 92.7% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchang
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Creative Planning lowered its stake in shares of Doximity, Inc. (NASDAQ: DOCS) by 6.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
CVNA last traded at $313.25 a share after finding support at $285.02, which was double-bottom support dating back to June 2025.
Dr Martens PLC (LSE:DOCS) shares stomped almost 7% lower to 76p after the bootmaker reported first half results in line with market expectations, saying it expects to offset the full-year effect of U
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
DOCS Q2 results benefit from the rise in AI-driven engagement. However, the stock plunges nearly 9% in pre-market trading.
Doximity, Inc. ( DOCS ) Q2 2026 Earnings Call November 6, 2025 5:00 PM EST Company Participants Perry Gold - Head of Investor Relations Jeffrey Tangney - Co-Founder, CEO & Chairperson Anna Bryson - Ch
While the top- and bottom-line numbers for Doximity (DOCS) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics comp
Doximity (DOCS) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.3 per share a year ago.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE